These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8662945)

  • 21. NF-kappa B site-mediated negative regulation of the HIV-1 promoter by CCAAT/enhancer binding proteins in brain-derived cells.
    Mondal D; Alam J; Prakash O
    J Mol Neurosci; 1994-1995; 5(4):241-58. PubMed ID: 7577367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutations in the interferon-sensitivity determining region of hepatitis C virus and transcriptional activity of the nonstructural region 5A protein.
    Fukuma T; Enomoto N; Marumo F; Sato C
    Hepatology; 1998 Oct; 28(4):1147-53. PubMed ID: 9755255
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transcription of the human immunodeficiency virus type 1 (HIV-1) promoter in central nervous system cells: effect of YB-1 on expression of the HIV-1 long terminal repeat.
    Sawaya BE; Khalili K; Amini S
    J Gen Virol; 1998 Feb; 79 ( Pt 2)():239-46. PubMed ID: 9472608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CBF/NF-Y functions both in nucleosomal disruption and transcription activation of the chromatin-assembled topoisomerase IIalpha promoter. Transcription activation by CBF/NF-Y in chromatin is dependent on the promoter structure.
    Coustry F; Hu Q; de Crombrugghe B; Maity SN
    J Biol Chem; 2001 Nov; 276(44):40621-30. PubMed ID: 11514576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calcium-sensitive transcriptional activation of the proximal CCAAT regulatory element of the grp78/BiP promoter by the human nuclear factor CBF/NF-Y.
    Roy B; Li WW; Lee AS
    J Biol Chem; 1996 Nov; 271(46):28995-9002. PubMed ID: 8910550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SV40 large T antigen transactivates the human cdc2 promoter by inducing a CCAAT box binding factor.
    Chen H; Campisi J; Padmanabhan R
    J Biol Chem; 1996 Jun; 271(24):13959-67. PubMed ID: 8662914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Three different polypeptides are necessary for DNA binding of the mammalian heteromeric CCAAT binding factor.
    Maity SN; Sinha S; Ruteshouser EC; de Crombrugghe B
    J Biol Chem; 1992 Aug; 267(23):16574-80. PubMed ID: 1644837
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple forms of C/EBP beta bind the EFII enhancer sequence in the Rous sarcoma virus long terminal repeat.
    Sears RC; Sealy L
    Mol Cell Biol; 1994 Jul; 14(7):4855-71. PubMed ID: 8007984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Two control elements in the hepatitis B virus S-promoter are important for full promoter activity mediated by CCAAT-binding factor.
    Bock CT; Kubicka S; Manns MP; Trautwein C
    Hepatology; 1999 Apr; 29(4):1236-47. PubMed ID: 10094970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Two different negative and one positive regulatory factors interact with a short promoter segment of the alpha 1 (I) collagen gene.
    Karsenty G; de Crombrugghe B
    J Biol Chem; 1990 Jun; 265(17):9934-42. PubMed ID: 2351683
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Oct-2 glutamine-rich and proline-rich activation domains can synergize with each other or duplicates of themselves to activate transcription.
    Tanaka M; Clouston WM; Herr W
    Mol Cell Biol; 1994 Sep; 14(9):6046-55. PubMed ID: 8065338
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcriptional activity of the Rous sarcoma virus long terminal repeat correlates with binding of a factor to an upstream CCAAT box in vitro.
    Greuel BT; Sealy L; Majors JE
    Virology; 1990 Jul; 177(1):33-43. PubMed ID: 2162108
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biochemical analysis of the B subunit of the heteromeric CCAAT-binding factor. A DNA-binding domain and a subunit interaction domain are specified by two separate segments.
    Maity SN; de Crombrugghe B
    J Biol Chem; 1992 Apr; 267(12):8286-92. PubMed ID: 1569083
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conservation of transcriptional activation functions of the NF-kappa B p50 and p65 subunits in mammalian cells and Saccharomyces cerevisiae.
    Moore PA; Ruben SM; Rosen CA
    Mol Cell Biol; 1993 Mar; 13(3):1666-74. PubMed ID: 8441404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. I kappa B/MAD-3 masks the nuclear localization signal of NF-kappa B p65 and requires the transactivation domain to inhibit NF-kappa B p65 DNA binding.
    Ganchi PA; Sun SC; Greene WC; Ballard DW
    Mol Biol Cell; 1992 Dec; 3(12):1339-52. PubMed ID: 1493333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Visna virus Tat protein: a potent transcription factor with both activator and suppressor domains.
    Carruth LM; Hardwick JM; Morse BA; Clements JE
    J Virol; 1994 Oct; 68(10):6137-46. PubMed ID: 8083955
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stable expression of a dominant negative mutant of CCAAT binding factor/NF-Y in mouse fibroblast cells resulting in retardation of cell growth and inhibition of transcription of various cellular genes.
    Hu Q; Maity SN
    J Biol Chem; 2000 Feb; 275(6):4435-44. PubMed ID: 10660616
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Positive and negative regulation of the human thymidine kinase promoter mediated by CCAAT binding transcription factors NF-Y/CBF, dbpA, and CDP/cut.
    Kim EC; Lau JS; Rawlings S; Lee AS
    Cell Growth Differ; 1997 Dec; 8(12):1329-38. PubMed ID: 9419421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanism for transcriptional gain of function resulting from chromosomal translocation in alveolar rhabdomyosarcoma.
    Bennicelli JL; Edwards RH; Barr FG
    Proc Natl Acad Sci U S A; 1996 May; 93(11):5455-9. PubMed ID: 8643596
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of the transcription start site core region and transcription factor YY1 in Rous sarcoma virus long terminal repeat promoter activity.
    Mobley CM; Sealy L
    J Virol; 1998 Aug; 72(8):6592-601. PubMed ID: 9658104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.